Literature DB >> 3570035

Effect of bedtime ranitidine on overnight gastric acid output and intragastric pH: dose/response study and comparison with cimetidine.

J B Chambers, D Pryce, J M Bland, T C Northfield.   

Abstract

A dose/response study has been carried out in seven patients with endoscopically proven duodenal ulcers in symptomatic remission, measuring intragastric pH and gastric acid output overnight after a bedtime dose of ranitidine (75 mg, 150 mg, and 300 mg); and the results have been compared with placebo and with bedtime cimetidine 400 mg. The currently recommended ranitidine maintenance dose (150 mg) was the optimum because it was significantly more effective than ranitidine 75 mg in terms of intragastric pH but not of acid output, and there was no difference from 300 mg in terms of either measurement. It was also significantly more effective than the currently recommended cimetidine maintenance dose (400 mg) in terms of inhibiting overnight acid output (92% vs 80% inhibition, p less than 0.05), and of maintaining intragastric pH above 5 (100% vs 17% of the overnight period, p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570035      PMCID: PMC1432688          DOI: 10.1136/gut.28.3.294

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Cimetidine suppression of nocturnal gastric secretion in active duodenal ulcer.

Authors:  G F Longstreth; V L Go; J R Malagelada
Journal:  N Engl J Med       Date:  1976-04-08       Impact factor: 91.245

2.  Positioning of subject and of nasogastric tube during a gastric secretion study.

Authors:  M A Hassan; M Hobsley
Journal:  Br Med J       Date:  1970-02-21

3.  Cimetidine once daily.

Authors:  M Delattre; B Dickson
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

4.  Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.

Authors:  T Gledhill; O M Howard; M Buck; A Paul; R H Hunt
Journal:  Gut       Date:  1983-10       Impact factor: 23.059

5.  pH stability and activity curves of pepsin with special reference to their clinical importance.

Authors:  D W Piper; B H Fenton
Journal:  Gut       Date:  1965-10       Impact factor: 23.059

6.  Comparison of cimetidine 800 mg once daily and 400 mg twice daily in acute duodenal ulceration.

Authors:  L Capurso; P R Dal Monte; F Mazzeo; G Menardo; A Morettini; A Saggioro; G Tafner
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-24

7.  Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcers.

Authors:  A Ireland; D G Colin-Jones; P Gear; P L Golding; J K Ramage; J G Williams; R J Leicester; C L Smith; G Ross; J Bamforth
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

8.  Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial.

Authors:  K R Gough; M G Korman; K D Bardhan; F I Lee; J P Crowe; P I Reed; R N Smith
Journal:  Lancet       Date:  1984-09-22       Impact factor: 79.321

9.  Nocturnal gastric acid secretion in duodenal ulcer: inhibition by cimetidine.

Authors:  S L Broor; G P Shrestha; S K Mehta; B K Sharma
Journal:  Am J Med Sci       Date:  1981 Nov-Dec       Impact factor: 2.378

10.  Final report on the United States Multicenter Trial comparing ranitidine to cimetidine as maintenance therapy following healing of duodenal ulcer.

Authors:  S E Silvis
Journal:  J Clin Gastroenterol       Date:  1985-12       Impact factor: 3.062

View more
  2 in total

1.  The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.

Authors:  H S Merki; L Witzel; D Kaufmann; M Kempf; J Neumann; E Scheurle; J Röhmel; R P Walt
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Two year maintenance treatment of duodenal ulcer disease with ranitidine 150 mg: a prospective multicentre randomised study. GEMUD (Groupe d'Etude de la Maladie Ulcéreuse Duodénale).

Authors:  P Ruszniewski; A Slama; M Pappo; M Mignon
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.